42
GMP AND cGMP GMP AND cGMP CONSIDERATIONS CONSIDERATIONS Dr. Basavaraj K. Nanjwade Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D. M.Pharm., Ph.D. Associate Professor Associate Professor Department of Pharmaceutics Department of Pharmaceutics KLE University KLE University BELGAUM - 590010 BELGAUM - 590010 By

GMP AND cGMP CONSIDERATIONS

Embed Size (px)

Citation preview

Page 1: GMP AND cGMP CONSIDERATIONS

GMP AND cGMP GMP AND cGMP CONSIDERATIONSCONSIDERATIONS

Dr. Basavaraj K. Nanjwade Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D.M.Pharm., Ph.D.

Associate ProfessorAssociate ProfessorDepartment of PharmaceuticsDepartment of Pharmaceutics

KLE UniversityKLE UniversityBELGAUM - 590010BELGAUM - 590010

By

Page 2: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 22

What is GMP ?What is GMP ?

GMP is that part of Quality assurance GMP is that part of Quality assurance which ensures that the products are which ensures that the products are consistently manufactured and controlled consistently manufactured and controlled to the Quality standards appropriate to to the Quality standards appropriate to their intended usetheir intended use

"GMP""GMP" - A set of principles and procedures - A set of principles and procedures which, when followed by manufacturers for which, when followed by manufacturers for therapeutic goods, helps ensure that the therapeutic goods, helps ensure that the products manufactured will have the products manufactured will have the required quality.required quality.

Page 3: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 33

What is cGMP ?What is cGMP ?

Usually see “cGMP” – where c = Usually see “cGMP” – where c = current, to emphasize that the current, to emphasize that the expectations are dynamicexpectations are dynamic

Page 4: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 44

Quality DefinitionQuality Definition

Quality of a medicinal product is Quality of a medicinal product is measured by it’s fitness for purpose . measured by it’s fitness for purpose . Safety and efficacy are not separable Safety and efficacy are not separable from Quality but part of itfrom Quality but part of it

Quality Safety Efficacy XQuality Safety Efficacy X

QualityQuality Safety EfficacySafety Efficacy

Page 5: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 55

Page 6: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 66

Good Manufacturing PracticesGood Manufacturing Practices

A basic tenet of GMP is that quality cannot A basic tenet of GMP is that quality cannot be tested into a batch of product but must be tested into a batch of product but must be built into each batch of product during be built into each batch of product during all stages of the manufacturing process.all stages of the manufacturing process.

It is designed to minimize the risks It is designed to minimize the risks involved in any pharmaceutical production involved in any pharmaceutical production that cannot be eliminated through testing that cannot be eliminated through testing the final product.the final product.

Page 7: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 77

Some of the main risks areSome of the main risks are

– unexpected contamination of products, causing unexpected contamination of products, causing damage to health or even death. damage to health or even death.

– incorrect labels on containers, which could incorrect labels on containers, which could mean that patients receive the wrong mean that patients receive the wrong medicine.medicine.

– insufficient or too much active ingredient, insufficient or too much active ingredient, resulting in ineffective treatment or adverse resulting in ineffective treatment or adverse effects.effects.

Page 8: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 88

Why GMP is importantWhy GMP is important

– A poor quality medicine may contain A poor quality medicine may contain toxic substances that have been toxic substances that have been unintentionally added. unintentionally added.

– A medicine that contains little or none of A medicine that contains little or none of the claimed ingredient will not have the the claimed ingredient will not have the intended therapeutic effect. intended therapeutic effect.

Page 9: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 99

GMP helps boost pharmaceutical GMP helps boost pharmaceutical export opportunitiesexport opportunities

Most countries will only accept import Most countries will only accept import and sale of medicines that have been and sale of medicines that have been manufactured to internationally manufactured to internationally recognized GMP.recognized GMP.

Governments seeking to promote their Governments seeking to promote their countries export of pharmaceuticals countries export of pharmaceuticals can do so by making GMP mandatory can do so by making GMP mandatory for all pharmaceutical production and for all pharmaceutical production and by training their inspectors in GMP by training their inspectors in GMP requirements.requirements.

Page 10: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 1010

GMP Covers…GMP Covers…

ALLALL aspects of production; from the starting aspects of production; from the starting materials, premises and equipment to the materials, premises and equipment to the training and personal hygiene of staff.training and personal hygiene of staff.

Detailed, written procedures are essential for Detailed, written procedures are essential for each process that could affect the quality of the each process that could affect the quality of the finished product. finished product.

There must be systems to provide documented There must be systems to provide documented proof that correct procedures are consistently proof that correct procedures are consistently followed at each step in the manufacturing followed at each step in the manufacturing process - every time a product is made.process - every time a product is made.

Page 11: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 1111

GMPGMP

The Quality of a formulation or a bulk The Quality of a formulation or a bulk drug depends on the Quality of thosedrug depends on the Quality of those

producing itproducing it GMP is the magic key that opens the GMP is the magic key that opens the

door of the Qualitydoor of the Quality In matter of GMP, swim with the In matter of GMP, swim with the

current and in matter of Quality current and in matter of Quality stand like a rock!stand like a rock!

Page 12: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 1212

QA, GMP & QC inter-relationship

QC

GMP

QA

Page 13: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 1313

QA, GMP & QC inter-relationship

It is the sum total of the organized arrangements

with the objective of ensuring that products

will be of the quality required for their

intended use

QA

Page 14: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 1414

QA, GMP & QC inter-relationship

Is that part of Quality Assurance aimed at

ensuring that products are consistently

manufactured to a quality appropriate to

their intended use

GMP

Page 15: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 1515

QA, GMP & QC inter-relationship

Is that part of GMP concerned with sampling, specification & testing, documentation & release procedures which

ensure that the necessary & relevant tests are performed & the product is released for use only after ascertaining

it’s quality

QC

Page 16: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 1616

QC and QAQC and QA

QC is that part of GMP QC is that part of GMP which is concerned which is concerned with sampling,with sampling,

specifications, testing specifications, testing and with in the and with in the organization, organization, documentation,and documentation,and release procedures release procedures which ensure that the which ensure that the necessary and relevant necessary and relevant tests are carried outtests are carried out

QA is the sum total QA is the sum total of organized of organized arrangements arrangements made with the made with the object of ensuring object of ensuring that product will be that product will be of the Quality of the Quality required by their required by their intended use.intended use.

Page 17: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 1717

QC and QAQC and QA

Operational Operational laboratory laboratory techniques and techniques and activities used to activities used to fulfill the fulfill the requirement of requirement of QualityQuality

All those planned All those planned or systematic or systematic actions necessary actions necessary to provide to provide adequate adequate confidence that a confidence that a product will satisfy product will satisfy the requirements the requirements for qualityfor quality

Page 18: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 1818

QC and QAQC and QA

QC is lab based QC is lab based QA is company QA is company basedbased

Page 19: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 1919

GMP guidelinesGMP guidelines GMP as per Schedule “M”GMP as per Schedule “M” www.cdsco.nic.inwww.cdsco.nic.in

GMP as per WHOGMP as per WHO www.who.intwww.who.int

GMP as per MCA now known as MHRAGMP as per MCA now known as MHRA www.mca.gov.ukwww.mca.gov.uk

GMP as per TGAGMP as per TGA www.tga.gov.auwww.tga.gov.au

GMP as per US FDAGMP as per US FDA www.fda.govwww.fda.gov GMP as per ICH guidelinesGMP as per ICH guidelines www.ich.orgwww.ich.org

Page 20: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 2020

GMPGMP

GMP in solid dosage formsGMP in solid dosage forms GMP in semisolid dosage formsGMP in semisolid dosage forms GMP in Liquid oralsGMP in Liquid orals GMP in Parenterals ProductionGMP in Parenterals Production GMP in Ayurvedic medicinesGMP in Ayurvedic medicines GMP in Bio technological productsGMP in Bio technological products GMP in Nutraceuticals and cosmeceuticalsGMP in Nutraceuticals and cosmeceuticals GMP in Homeopathic medicinesGMP in Homeopathic medicines

Page 21: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 2121

GMPGMP

Good Manufacturing PracticeGood Manufacturing Practice Good Management PracticeGood Management Practice Get More ProfitGet More Profit Give more ProductionGive more Production GMP Training with out tearsGMP Training with out tears

Page 22: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 2222

GMPGMP

All past GMPs are history….It is All past GMPs are history….It is looking like in rear view mirror and looking like in rear view mirror and drivingdriving

Page 23: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 2323

Ten Principles of GMPTen Principles of GMP1.1. Design and construct the facilities and Design and construct the facilities and

equipments properlyequipments properly2.2. Follow written procedures and InstructionsFollow written procedures and Instructions3.3. Document workDocument work4.4. Validate workValidate work5.5. Monitor facilities and equipmentMonitor facilities and equipment6.6. Write step by step operating procedures and Write step by step operating procedures and

work on instructionswork on instructions7.7. Design ,develop and demonstrate job Design ,develop and demonstrate job

competencecompetence8.8. Protect against contaminationProtect against contamination9.9. Control components and product related Control components and product related

processesprocesses 10.10. Conduct planned and periodic auditsConduct planned and periodic audits

Page 24: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 2424

Beyond GMPBeyond GMP

Reduce pollution -Reduce pollution - Zero discharge Zero discharge Adaptation of environment friendly Adaptation of environment friendly

methodsmethods Consideration for better and Consideration for better and

healthier life tomorrowhealthier life tomorrow Consideration of ethics in lifeConsideration of ethics in life One should begin with end in mind One should begin with end in mind

otherwise it will be the beginning of otherwise it will be the beginning of the end the end

Page 25: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 2525

Cost of effective GMPCost of effective GMP In fact Cost benefits – positive cost In fact Cost benefits – positive cost

benefits of GMP/QAbenefits of GMP/QA Good plant lay out, Smooth work flows, Good plant lay out, Smooth work flows,

Efficient documentation systems, well Efficient documentation systems, well controlled process, good stores lay outs controlled process, good stores lay outs and stores records- These are Good and stores records- These are Good manufacturing practicesmanufacturing practices

Reduction in work in process and Reduction in work in process and inventory holding costsinventory holding costs

Avoidance of cost of Quality failure ( cost Avoidance of cost of Quality failure ( cost of waste, of rework, of recall, of consumer of waste, of rework, of recall, of consumer compensation and of loss of company compensation and of loss of company reputation)reputation)

Page 26: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 2626

List of important documents in GMPList of important documents in GMP

PoliciesPolicies SOPSOP SpecificationsSpecifications MFR (Master Formula Record)MFR (Master Formula Record) BMRBMR ManualsManuals Master plans/ filesMaster plans/ files Validation protocolsValidation protocols Forms and FormatsForms and Formats RecordsRecords

Page 27: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 2727

10 attributes of a good document10 attributes of a good document

1.1. AccurateAccurate2.2. ClearClear3.3. CompleteComplete4.4. ConsistentConsistent5.5. IndelibleIndelible6.6. LegibleLegible7.7. TimelyTimely8.8. Direct Direct 9.9. AuthenticAuthentic10.10. AuthorizedAuthorized

Page 28: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 2828

Certifying agenciesCertifying agencies

ICH.ICH. www.ich.orgwww.ich.org

WHO. WHO. www.who.intwww.who.int

US FDA.US FDA. www.fda.govwww.fda.gov

EU/EMEA.EU/EMEA. www.emea.europa.euwww.emea.europa.eu

Page 29: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 2929

How do GMPs of different countries How do GMPs of different countries compare?compare?

At a high level, GMPs of various nations are very At a high level, GMPs of various nations are very similar; most require things like: similar; most require things like:

Equipment and facilities being properly Equipment and facilities being properly

designed, maintained, and cleaneddesigned, maintained, and cleaned Standard Operating Procedures (SOPs) be Standard Operating Procedures (SOPs) be

written and approvedwritten and approved An independent Quality unit (like Quality An independent Quality unit (like Quality

Control and/or Quality Assurance)Control and/or Quality Assurance) Well trained personnel and managementWell trained personnel and management

Page 30: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 3030

cGMP For Finished PharmaceuticalscGMP For Finished Pharmaceuticals

1.1. General ProvisionGeneral Provision2.2. Organization & PersonnelOrganization & Personnel3.3. Building & FacilitiesBuilding & Facilities4.4. EquipmentEquipment5.5. Control of Components & Drug Product Control of Components & Drug Product

Containers & ClosuresContainers & Closures6.6. Production & Process ControlProduction & Process Control7.7. Packaging & Labeling ControlPackaging & Labeling Control8.8. Handling & DistributionHandling & Distribution9.9. Laboratory ControlLaboratory Control10.10. Records & ReportsRecords & Reports11.11. Returned & Salvaged DrugsReturned & Salvaged Drugs

Page 31: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 3131

General ProvisionGeneral Provision

1.1. Scope Scope

2.2. DefinitionsDefinitions

Page 32: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 3232

Organization & PersonnelOrganization & Personnel

1.1. Responsibilities of quality control Responsibilities of quality control unit. unit.

2.2. Personnel qualifications. Personnel qualifications.

3.3. Personnel responsibilitiesPersonnel responsibilities. .

4.4. Consultants.Consultants.

Page 33: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 3333

Building & FacilitiesBuilding & Facilities

1.1. Design and construction features.Design and construction features. 2.2. Lighting.Lighting.3.3. Ventilation, air filtration, air heating Ventilation, air filtration, air heating

and cooling.and cooling. 4.4. Plumbing.Plumbing. 5.5. Sewage and refuse. Sewage and refuse. 6.6. Washing and toilet facilities. Washing and toilet facilities. 7.7. Sanitation.Sanitation. 8.8. MaintenanceMaintenance. .

Page 34: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 3434

EquipmentEquipment

1.1. Equipment design, size, and Equipment design, size, and location.location.

2.2. Equipment construction. Equipment construction. 3.3. Equipment cleaning and Equipment cleaning and

maintenance.maintenance. 4.4. Automatic, mechanical, and Automatic, mechanical, and

electronic equipment.electronic equipment. 5.5. Filters. Filters.

Page 35: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 3535

Control of Components & Drug Control of Components & Drug Product Containers & ClosuresProduct Containers & Closures

1.1. General requirements. General requirements. 2.2. Receipt & storage of untested components, Receipt & storage of untested components,

drug product containers, and closures. drug product containers, and closures. 3.3. Testing and approval or rejection of Testing and approval or rejection of

components, drug product containers, and components, drug product containers, and closures. closures.

4.4. Use of approved components, drug product Use of approved components, drug product containers, and closures. containers, and closures.

5.5. Retesting of approved components, drug Retesting of approved components, drug product containers, and closures. product containers, and closures.

6.6. Rejected components, drug product containers, Rejected components, drug product containers, and closures.and closures.

7.7. Drug product containers and closures. Drug product containers and closures.

Page 36: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 3636

Production & Process ControlProduction & Process Control

1.1. Written procedures; Written procedures; deviationsdeviations. . 2.2. Charge-in of components.Charge-in of components.3.3. Calculation of yield. Calculation of yield. 4.4. Equipment identification.Equipment identification. 5.5. Sampling and testing of in-process Sampling and testing of in-process

materials and drug products. materials and drug products. 6.6. Time limitations on production. Time limitations on production. 7.7. Control of microbiological contamination.Control of microbiological contamination.8.8. Reprocessing. Reprocessing.

Page 37: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 3737

Packaging & Labeling ControlPackaging & Labeling Control

1.1. Materials examination and usage Materials examination and usage criteria.criteria.

2.2. Labeling issuance. Labeling issuance. 3.3. Packaging and labeling operations.Packaging and labeling operations. 4.4. Tamper-evident packaging Tamper-evident packaging

requirements for over-the-counter requirements for over-the-counter (OTC) human drug products. (OTC) human drug products.

5.5. Drug product inspection. Drug product inspection. 6.6. Expiration dating. Expiration dating.

Page 38: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 3838

Handling & DistributionHandling & Distribution

1.1. Warehousing procedures.Warehousing procedures.

2.2. Distribution procedures. Distribution procedures.

Page 39: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 3939

Laboratory ControlLaboratory Control

1.1. General requirements.General requirements.

2.2. Testing and release for distribution. Testing and release for distribution.

3.3. Stability testing.Stability testing.

4.4. Special testing requirements.Special testing requirements.

5.5. Reserve samples. Reserve samples.

6.6. Laboratory animals. Laboratory animals.

7.7. Penicillin contamination. Penicillin contamination.

Page 40: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 4040

Records & ReportsRecords & Reports

1.1. General requirements. General requirements. 2.2. Equipment cleaning and use log. Equipment cleaning and use log. 3.3. Component, drug product container, closure, Component, drug product container, closure,

and labeling records.and labeling records. 4.4. Master production and control records.Master production and control records. 5.5. Batch production and control records. Batch production and control records.

6.6. ProductionProduction record review. record review. 7.7. Laboratory records. Laboratory records. 8.8. Distribution records. Distribution records. 9.9. Complaint files. Complaint files.

Page 41: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 4141

Returned & Salvaged Drug Returned & Salvaged Drug ProductsProducts

1.1. Returned drug products. Returned drug products.

2.2. Drug product salvaging. Drug product salvaging.

Page 42: GMP AND cGMP CONSIDERATIONS

22/10/200822/10/2008 Department of PharmaceuticsDepartment of Pharmaceutics 4242

THANK YOUTHANK YOUE-mail: [email protected]

Cell No: 9448716277